BioSyntech, Inc. · Laval, PQ Canada ·(Toronto: BSY)
Company Description
View BioSyntech, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window BioSyntech is a development-stage company specializing in the creation and development of biotherapeutic thermogels to be used for human tissue repair and therapeutic delivery. The BST-Gels are liquid at room temperature but solidify at human body temperature, and they are classified as medical devices by the FDA and other regulators. Various products in development include BST-CarGel (cartilage repair), BST-InPod (heel cushioning), and BST-DermOn (chronic wound healing). For now, the company makes its money primarily from the sale of Ultrasan, a pure form of chitosan (derived from chitin and is also used in the thermogels), and providing analytical services to support Ultrasan. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key BioSyntech, Inc. Financials
| Company Type | Public - Toronto: BSY Single Location |
| Fiscal Year-End | March |
| 2008 Sales (mil.) | $0.3 |
| Employees | 40 |
BioSyntech, Inc. Executives
17 executives listed for BioSyntech, Inc.'s Laval, PQ location.
| Title | Name & Bio | Contact |
| Chairman | Michel Lagueux | Network |
| CEO | Jeanne Bertonis | Network |
| CFO | Antoinette Lizzi | Network |
Competition
Competitive Landscape for BioSyntech, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top BioSyntech, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!